Kim, FJ. Handbook Experimental Pharmacology.

Oyer is now a postdoc at Drexel University studying Sigma 1, a so-called “chaperone protein” that influences other proteins and pathways involved in the amount of stress cells endure.

PHILADELPHIA--(BUSINESS WIRE)--Context Therapeutics, a biotechnology company dedicated to creating new medicines for cancer, fibrosis, and neurodegenerative disease, today announced that the company has entered into agreements with three research partners.